Even the best medicine in the world won’t work if it never reaches the patient, and insufficient access is a large and growing problem. The Abacus Medicine Group offers a range of different solutions and services that provide better access to life-critical medicine at affordable prices to millions ...
Even the best medicine in the world won’t work if it never reaches the patient, and insufficient access is a large and growing problem.
The Abacus Medicine Group offers a range of different solutions and services that provide better access to life-critical medicine at affordable prices to millions of patients across the world. Our business purpose holds a substantial positive impact on healthcare systems and society and is something we're proud of.
The company was founded in 2004 by CEO Flemming Wagner and Medical Director John Wagner and has experienced significant growth ever since. Today, we are more than 1,750 colleagues moving healthcare in Europe and beyond.
The Abacus Medicine Group is among the 100 largest Danish companies.
The Group operates as four brands: Abacus Medicine, Pluripharm, Abacus Medicine Pharma Services and Originalis.
Learn more about the Abacus Medicine Group on our website below.